Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN).

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 157f73294b3de9444f6e6b2b95a8c542288eebb3
First added on: Jan 16, 2026